drugset / Trial / NCT00159692

Amlodipine Diabetic Hypertension Efficacy Response Trial

NCT00159692

Phase 4 Completed 739 enrolled Viatris Inc.
RandomizedSingle-groupDouble-blindTreatment

Summary

To evaluate the percentage of subjects that reach the diabetic hypertensive blood pressure goal of \<130/80 with amlodipine versus placebo in subjects initially treated with quinapril or losartan.

Timeline

Start
2003-03
Primary completion
Completion
2005-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified

Indications